Marker Therapeutics, Inc. (MRKR)

2.10 +0.06 (+2.94%) USD  |  NASDAQ  |  Jan 23, 16:00
2.09 -0.01 (-0.48%) After-Hours: 20:00
More

Marker Therapeutics Return on Invested Capital (10y Median)

Return on Invested Capital (10y Median) Chart

View Return on Invested Capital (10y Median) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (10y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (10y Median) Range, Past 5 Years

View Return on Invested Capital (10y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (10y Median) Benchmarks

View Return on Invested Capital (10y Median) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade